KYNB
Financials
- Market Capitalization 32.47 M
- Employee 34
- Founded 1993
- CEO N/A
- Website www.kyntrabio.com
- Headquarter California, United States
- FIGI BBG000FW5ZL6
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4415 |  LITS Lite Strategy, Inc. - Common Stock | 0.98 USD | -2.00% | -5.77% | +1.03% | -67.11% | 33.34 M USD | ||
| 4429 |  QNCX Quince Therapeutics, Inc. - Common Stock | 33.42 USD | +2.83% | +1.18% | +71.30% | +2113.25% | 33.99 M USD | ||
| 4434 |  ATNM Actinium Pharmaceuticals, Inc. Common Stock | 1.02 USD | -1.92% | -9.73% | +20.00% | -1.92% | 32.07 M USD | ||
| 4440 |  BCTX BriaCell Therapeutics Corp. - Common Shares | 3.72 USD | +0.27% | -8.82% | +2.76% | -49.59% | 32.36 M USD |
Frequently asked questions about Kyntra Bio, Inc. Common Stock
What is the Kyntra Bio, Inc. Common Stock stock price today?
The current price of Kyntra Bio, Inc. Common Stock (KYNB) is 8.02. Over the past 24 hours, the stock has changed by +0.25%. Follow the KYNB chart for real-time price dynamics.
What is the stock ticker of Kyntra Bio, Inc. Common Stock?
Kyntra Bio, Inc. Common Stock trades under the ticker KYNB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Kyntra Bio, Inc. Common Stock stock going up?
KYNB has changed by +7.08% over the last week, +15.56% over the last month, and -15.67% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Kyntra Bio, Inc. Common Stock?
Kyntra Bio, Inc. Common Stock currently has a market capitalization of 32.47 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Kyntra Bio, Inc. Common Stock earnings last quarter?
Last quarter, Kyntra Bio, Inc. Common Stock reported earnings of 2.96 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Kyntra Bio, Inc. Common Stock revenue for the last quarter?
Kyntra Bio, Inc. Common Stock reported quarterly revenue of -1.47 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Kyntra Bio, Inc. Common Stock net income for the last quarter?
Kyntra Bio, Inc. Common Stock reported net income of 11.97 M for the last quarter. The previous quarter showed -15.2 M, which means net income changed by +178.79%.
How many employees does Kyntra Bio, Inc. Common Stock have?
As of the latest available data, Kyntra Bio, Inc. Common Stock has 34 employees. Workforce size can provide additional context about the company's scale and operations.
What is Kyntra Bio, Inc. Common Stock EBITDA?
Kyntra Bio, Inc. Common Stock EBITDA is -17.67 M, and its EBITDA margin is 1 198.51%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Kyntra Bio, Inc. Common Stock stock?
You can buy Kyntra Bio, Inc. Common Stock (KYNB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Kyntra Bio, Inc. Common Stock stock?
Investing in Kyntra Bio, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KYNB chart and related analysis on metatrader.com as part of your research.